WHO ICTRP trial
A clinical trial to study the effects of an Ayurvedic medicine, Haldi 30 (…
CTRI/2020/07/026841 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/07/026841 |
|---|---|
| Public title | A clinical trial to study the effects of an Ayurvedic medicine, Haldi 30 ( Turmeric extract ) drops in patients with Corona virus infection. |
| Scientific title | Efficacy of Ayurvedic Medicine Haldi 30 drops as an Add on medication to standard of care in adult patients of mild to moderate COVID 19. A Phase II randomized, single - blind, parallel group, placebo - controlled trial. |
| Primary sponsor | Dr Sarang Phadke |
| Secondary sponsors | Col Suresh Purushottam Gadgil;Mr Anant Krishnaji Joshi;Mr Narahar Krishna Phadke;Mr Nikhil Vishwas Ranade;Mr Sunil Danekar;Mr Vishwas Digambar Ranade;Sanmarga Pratishthan |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere |
| Interventions | Intervention1: Standard of care plus Haldi 30 drops: Standard of care plus 3 drops PO at 6 AM, 10 AM, 2 PM, 6 PM, 10 PM. No liquid or solid food or oral medication up to 20 minutes after drug administration. Control Intervention1: Standard… |
| Registration date | Jul 28, 2020 |
| Target size | 260 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: